share_log

BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo

BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo

简介-Bicryst PharmPharmticals-3月18日,Co撤回了Orladeyo的孤儿药物产品指定申请
路透社 ·  2021/03/19 06:13

March 18 (Reuters) - BioCryst Pharmaceuticals Inc :
   * BIOCRYST PHARMACEUTICALS - ON MARCH 18, CO WITHDREW ITS APPLICATION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ORLADEYO™ (BEROTRALSTAT) IN THE EU

Source text for Eikon: [ID: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

路透3月18日电-BioCryst PharmPharmticals Inc:*BioCryst PharmPharmticals-3月18日,CO撤回了其在欧盟为ORLADEYO™(BEROTRALSTAT)指定孤儿药品的申请Eikon的源文本:[ID:进一步的公司覆盖范围:(Reurs.Briefs@thomsonreurs.com;)

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发